The overall process begins with cDNA or oligonucleotides spotted in two-dimensional arrays onto glass slides or nylon membranes, or synthesized on biochips using technology borrowed from the ...

Pfizer will strengthen its oncology portfolio through the Array acquisition, expected to be completed in H2-2019. At $48/share, the all-cash deal will be financed by debt and cash, putting the ...

Multipixel-array (MPA) sensing for target detection within specific distances combines the benefits of background suppression, sharply defined sensing, and insensitivity to object color with the ...

What: Shares of Array BioPharma, a biopharmaceutical company focused on developing novel small molecule cancer drugs, surged just shy of 10% on Monday following a hefty price target hike from ...

Stifel Nicolaus boosted its price target on cancer drug developer Array BioPharma by a substantial amount on Monday. Is this price hike warranted or is it full of fluff? So what: Stifel kept its buy ...